Nycomed sells catheter business in $15million MBO (management buy out)
This article was originally published in Clinica
Executive Summary
Nycomed Amersham, the UK based imaging agent and genetic discovery company, has rid itself of another non-core business. The imaging division is selling its interventional medical device subsidiary to a management buyout team lead by the current president of the division, for £10 million ($15 million).